STOCK TITAN

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th

(Moderate)
(Neutral)
Tags

BIO-key (NASDAQ: BKYI) announced that CEO Michael DePasquale will be available for virtual investor meetings during H.C. Wainwright’s 28th Annual Global Investment Conference on September 15 and 17, 2026. BIO-key’s on-demand presentation will be accessible to registered attendees starting September 11, 2026 at 7:00 a.m. ET via the conference website on the Technology, Media & Telecommunications Growth Track (Track 2).

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

BIO-key's prior Q2 2026 earnings announcement was followed by a -15.65% 24-hour reaction, adding cau...
Analysis

BIO-key's prior Q2 2026 earnings announcement was followed by a -15.65% 24-hour reaction, adding caution to this conference appearance. Low short positioning is a separate risk indicator; the presentation's disclosed content remains the key item to monitor.

Key Figures

Conference edition: 28th Annual Meeting date: September 15 Meeting date: September 17 +2 more
5 metrics
Conference edition 28th Annual H.C. Wainwright Global Investment Conference
Meeting date September 15 Virtual investor meetings
Meeting date September 17 Virtual investor meetings
Presentation availability September 11 at 7:00 a.m. ET On-demand conference presentation
Users secured Over 40 million users BIO-key IAM software description

Historical Context

5 past events · Latest: Aug 13 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 13 Q2 earnings Positive -15.7% Revenue increased while gross margin expanded and net loss narrowed.
Aug 11 Warrant inducement Negative -6.5% Discounted warrant exercise generated proceeds but added new warrants.
Aug 10 Security contract Positive +3.5% Portuguese national security agency selected BIO-key and Visualforma.
Aug 7 Investor call Neutral +1.3% Company scheduled its Q2 investor call and webcast.
Aug 6 Strategic partnership Positive -1.5% Partnership expanded identity-security distribution across Saudi education.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

BIO-key's positive operating and business announcements produced mixed reactions, including notable post-announcement declines.

Key Terms

identity and access management (iam), biometric authentication, passwordless
3 terms
identity and access management (iam) technical
"biometric-centric, multi-factor identity and access management (IAM) software"
Identity and access management (IAM) is the set of tools and practices a company uses to control who can enter its digital systems and what they can do, like assigning and checking virtual keys for employees, contractors and customers. Investors care because strong IAM reduces the risk of costly data breaches, regulatory fines and downtime, while weak IAM can damage trust, trigger expenses and harm a company’s valuation.
biometric authentication technical
"biometric authentication technologies"
Biometric authentication uses a person’s unique physical or behavioral traits—such as fingerprints, facial features, iris patterns, or voice—to verify identity instead of passwords or codes. For investors, it matters because faster, more secure login methods can boost customer trust and reduce fraud-related costs, while also creating opportunities and risks around technology adoption, data privacy rules, and the companies that build or supply the biometric systems.
passwordless technical
"tokenless, and passwordless biometric options"
Passwordless describes authentication methods that let users access accounts without typing a traditional password, using alternatives like a fingerprint, a one-time code, a security key, or a trusted device instead. For investors, it matters because replacing passwords can cut security breach risk, lower customer support and compliance costs, and improve user conversion — like replacing fragile paper tickets with a secure, easy-to-scan digital pass that reduces theft and lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HOLMDEL, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, announced that its CEO Michael DePasquale will be available for virtual meetings at H.C. Wainwright’s 28th Annual Global Investment Conference Tuesday, September 15th and Thursday, September 17th. Contact your H.C. Wainwright representative or Lily Khaykina at lk@hcwco.com to schedule a meeting.

Conference Presentation Available on Demand
BIO-key’s conference presentation will be available on demand to registered attendees via the conference website beginning on Friday, September 11th at 7:00 a.m. ET and throughout the conference on the Technology, Media & Telecommunications, Growth Track (Track 2).

H.C. Wainwright & Co. is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services across multiple sectors and regions. H.C. Wainwright also provides research and sales and trading services to institutional investors. The 28th Annual Global Investment Conference will feature leading companies across various growth segments.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key 
Facebook – Corporate:https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate:https://www.linkedin.com/company/bio-key-international
X – Corporate:@BIOkeyIntl
X – Investors:@BIO_keyIR
StockTwits:BIO_keyIR


Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800


FAQ

When will BIO-key (NASDAQ: BKYI) participate in the H.C. Wainwright Global Investment Conference 2026?

BIO-key will participate in H.C. Wainwright’s 28th Annual Global Investment Conference on Tuesday, September 15, and Thursday, September 17, 2026. According to BIO-key, CEO Michael DePasquale will be available for virtual investor meetings on those dates through H.C. Wainwright.

How can investors schedule a virtual meeting with BIO-key (BKYI) at the September 2026 H.C. Wainwright conference?

Investors can schedule virtual meetings with BIO-key’s CEO through their H.C. Wainwright representative or by contacting Lily Khaykina at lk@hcwco.com. According to BIO-key, meetings are available during the conference dates of September 15 and 17, 2026.

When and where is BIO-key’s on-demand presentation available for the H.C. Wainwright 2026 Global Investment Conference?

BIO-key’s conference presentation will be available on demand to registered attendees starting Friday, September 11, 2026 at 7:00 a.m. ET. According to BIO-key, it is accessible via the conference website on the Technology, Media & Telecommunications, Growth Track (Track 2).

What does BIO-key (NASDAQ: BKYI) do in the biometric security and IAM market?

BIO-key provides biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. According to BIO-key, its PortalGuard IAM platform supports phoneless, tokenless and passwordless biometric options, delivered as cloud-hosted or on-premise solutions for secure access to systems and high-value transactions.

How can investors contact BIO-key (BKYI) investor relations for more information about the 2026 conference?

Investors can contact BIO-key’s investor relations via Catalyst IR at BKYI@catalyst-ir.com or by calling 212-924-9800. According to BIO-key, William Jones and David Collins of Catalyst IR handle investor inquiries related to the company and its activities.